Metraipolis › archive › dc_262a567f0ec5

Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling — Europe PMC PMID:41699259

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41699259
DOI
10.1038/s44321-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-05T17:54:27.469Z
SHA-256 of the archived text
97108629b43a3860d9cc085e1c3bead56178408a0e189c9d12a5166d358fb6cf
Stable URL of this page
https://metraipolis.com/documento/dc_262a567f0ec5

How to cite

Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling — Europe PMC PMID:41699259 — Europe PMC (en), https://europepmc.org/article/MED/41699259 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_262a567f0ec5 (Metraipolis archive dc_262a567f0ec5, sha256 97108629b43a3860d9cc085e1c3bead56178408a0e189c9d12a5166d358fb6cf)
BibTeX
@misc{dc262a567f0ec5,
  title = {Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling — Europe PMC PMID:41699259},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41699259},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_262a567f0ec5; sha256 97108629b43a3860d9cc085e1c3bead56178408a0e189c9d12a5166d358fb6cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41699259. Agents can read the archived copy with the MCP tool read_document.